KANGHUI PHARMACEUTICAL's subsidiary Shaanxi Youbang has suspended production
I'm PortAI, I can summarize articles.
KANGHUI PHARMACEUTICAL's subsidiary Shaanxi Youbang has decided to fully suspend production in Workshop 1, Workshop 2, and Workshop 3 due to intensified market competition and ongoing losses. The suspension aims to avoid further losses and protect shareholder interests. Shaanxi Youbang mainly produces chemical drug intermediates, with an expected net profit of -52.5128 million yuan in 2024, impacting the company's net profit attributable to shareholders by 29.88%. Future production resumption will be determined based on market conditions
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments